I) DTPa-HepB-IPV: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.2 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80.
II) Hib: polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, lactosum, aluminium 0.12 mg ut aluminii phosphas, pro praeparatione.
I) et II) corresp. DTPa-HepB-IPV + Hib: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.32 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, lactosum, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80.
Packungsbestandteile
II
Suspension injectable
BAG: Active Agent
Dose
Haemagglutinium Filamentosum (B. Pertussis)
25 mcg
Haemophilus Influenzae b Polysaccharida (Prp)
10 mcg
Pertactinum (B. Pertussis)
8 mcg
Toxoidum Diphtheriae
30 UI
Toxoidum Pertussis
25 mcg
Toxoidum Tetani
40 UI
Vaccinum Hepatitidis b (Adnr) Hbsag
10 mcg
Virus Poliomyelitis Typus 1 Inactivatum (Mahoney)
40 UI
Virus Poliomyelitis Typus 2 Inactivatum (Mef1)
8 UI
Virus Poliomyelitis Typus 3 Inactivatum (Saukett)
32 UI
Inactive agents
Dose
Aluminii Phosphas
Conjugata cum Toxoido Tetani
10 µg
Lactosum
Polysaccharida Haemophili Influenzae Typus B
20752
I
Suspension injectable
Active Agent
Dose
Haemagglutininum Filamentosum (B. Pertussis)
25µg / 0.5ml
Hepatitidis b viri Antigenum Adnr
10µg / 0.5ml
Pertactinum (B. Pertussis)
8µg / 0.5ml
Toxoidum Diphtheriae
30U.I. / 0.5ml
Toxoidum Pertussis
25µg / 0.5ml
Toxoidum Tetani
40U.I. / 0.5ml
Virus Poliomyelitis Typus 1 Inactivatus (Mahoney)
40U.I. / 0.5ml
Virus Poliomyelitis Typus 2 Inactivatus (Mef1)
8U.I. / 0.5ml
Virus Poliomyelitis Typus 3 Inactivatus (Saukett)
32U.I. / 0.5ml
BAG: Active Agent
Dose
Haemagglutinium Filamentosum (B. Pertussis)
25 mcg
Haemophilus Influenzae b Polysaccharida (Prp)
10 mcg
Pertactinum (B. Pertussis)
8 mcg
Toxoidum Diphtheriae
30 UI
Toxoidum Pertussis
25 mcg
Toxoidum Tetani
40 UI
Vaccinum Hepatitidis b (Adnr) Hbsag
10 mcg
Virus Poliomyelitis Typus 1 Inactivatum (Mahoney)
40 UI
Virus Poliomyelitis Typus 2 Inactivatum (Mef1)
8 UI
Virus Poliomyelitis Typus 3 Inactivatum (Saukett)
32 UI
Inactive agents
Dose
Aluminii Hydroxidum Hydricum ad Adsorptionem
Aluminii Phosphas
Medium
199
Sodium Chlorure
Source
Data was imported : 08.11.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
